Loading...

Cellectis S.A.

CMVLF•PNK
Healthcare
Biotechnology
$2.58
$0.00(0.00%)

Cellectis S.A. (CMVLF) Stock Overview

Explore Cellectis S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.4/100

Key Financials

Market Cap186M
P/E Ratio-4.26
EPS (TTM)$-0.67
ROE-0.46%
Fundamental Analysis

AI Price Forecasts

1 Week$1.25
1 Month$1.83
3 Months$1.91
1 Year Target$0.79

CMVLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellectis S.A. (CMVLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.79.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.26 and a market capitalization of 186M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;